Not applicableEnded earlyNCT01722890What this trial is testingCharactHer. ICORG 12-09, V3Who this might be right forHER2-positive Breast CancerTNM Stage II-IV Breast Cancer Cancer Trials Ireland 130
Testing effectiveness (Phase 2)UnknownNCT02885766What this trial is testingStudy to Evaluate Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy of PF-114 for Oral Administration in Adults With Ph+ Chronic Myeloid Leukemia, Which is Resistant to the 2-nd Generation Bcr-Abl Inhibitors or Has T315I Mutation in the BCR-ABL GeneWho this might be right forChronic Myeloid LeukemiaLeukemia, Myelogenous, Chronic, BCR-ABL Positive Fusion Pharma LLC 65
Not applicableUnknownNCT02600442What this trial is testingAssessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular MarkersWho this might be right forBreast NeoplasmsBreast Cancer Assistance Publique - Hôpitaux de Paris 168
Testing effectiveness (Phase 2)Study completedNCT01774630What this trial is testingMulticenter Single-arm Pilot Study Evaluating Efficacy of Nilotinib in CML Patients With Molecular Relapse After Glivec Discontinuation Within the Context of the STIM Trials (STIM and STIM2)Who this might be right forLeukemia, Myelogenous, Chronic, BCR-ABL Positive University Hospital, Bordeaux 31
Not applicableUnknownNCT05642767What this trial is testingMolecular Detection Of Efflux Pump and Virulence Factors Genes in Pseudomonas AeruginosaWho this might be right forPseudomonas Aeruginosa Sohag University 75
Testing effectiveness (Phase 2)Looking for participantsNCT07407920What this trial is testingPh2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR TrialWho this might be right forAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Early Stage HER2-Positive Breast Carcinoma+1 more M.D. Anderson Cancer Center 120
Testing effectiveness (Phase 2)Study completedNCT02001818What this trial is testingPegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid LeukaemiaWho this might be right forChronic Myeloid Leukaemia Australasian Leukaemia and Lymphoma Group 60
Testing effectiveness (Phase 2)Study completedNCT01453257What this trial is testingStudy of Target-Guided Chemotherapy in Metastatic Colorectal PatientsWho this might be right forProgression Free Survival Grupo Hospital de Madrid 72
Testing effectiveness (Phase 2)Looking for participantsNCT01042379What this trial is testingI-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerWho this might be right forBreast NeoplasmsBreast CancerBreast Tumors+8 more QuantumLeap Healthcare Collaborative 5,000
Testing effectiveness (Phase 2)Study completedNCT01342679What this trial is testingComplete Molecular Response for Chronic Myeloid Leukemia in Chronic Phase Patients, Treated With DasatinibWho this might be right forChronic Myeloid Leukemia Kanto CML Study Group 21
Testing effectiveness (Phase 2)Study completedNCT00466726What this trial is testingVaccine Therapy in Treating Patients With Philadelphia Chromosome-Positive Chronic Myelogenous LeukemiaWho this might be right forLeukemia Gruppo Italiano Malattie EMatologiche dell'Adulto 57
Not applicableStudy completedNCT02842333What this trial is testingStudy of Predictive Immunological Parameters of Molecular Complete Remission in Patients With Chronic Myelogenous Leukemia in Chronic Phase and Treated With Tyrosine Kinase InhibitorWho this might be right forChronic Leukemia Centre Hospitalier Universitaire de Besancon 57